Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             15 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acknowledgment to Referees 2015
10 4 p. 449-451
artikel
2 A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines Shi, Yi
2015
10 4 p. 565-573
artikel
3 Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo Young, Natalie R.
2014
10 4 p. 501-508
artikel
4 Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer Zhao, Yue
2015
10 4 p. 535-548
artikel
5 Aptamer-Functionalized Nanoparticles as “Smart Bombs”: The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment Benedetto, Gregory
2015
10 4 p. 467-485
artikel
6 A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma Penter, Livius
2015
10 4 p. 523-533
artikel
7 Comparison of Two Prognostic Models in Patients with Metastatic Renal Cancer Treated with Sunitinib: a Retrospective, Registry-Based Study Kubackova, Katerina
2015
10 4 p. 557-563
artikel
8 Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor Kang, Guhyun
2015
10 4 p. 597-601
artikel
9 Effectiveness and safety of post-induction phase bevacizumab treatment for patients with non-small-cell lung cancer: results from the ARIES observational cohort study Kosty, Michael P.
2015
10 4 p. 509-516
artikel
10 Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy Despierre, Evelyn
2015
10 4 p. 583-596
artikel
11 Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents García-Alfonso, Pilar
2015
10 4 p. 453-465
artikel
12 Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy Santoni, Matteo
2015
10 4 p. 517-522
artikel
13 Renal Toxicities of Targeted Therapies Abbas, Anum
2015
10 4 p. 487-499
artikel
14 The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study Fiala, Ondrej
2015
10 4 p. 549-555
artikel
15 The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AX Wang, Yufeng
2015
10 4 p. 575-581
artikel
                             15 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland